rivaroxaban
bayer
['invictus', 'rivaroxaban']
3) in pts with rheumatic heart disease and af, rct evidence supports vka use over rivaroxaban, with decreased composite of cv events and death with vka and no increase in bleeding. evidence: invictus #esccongress 
Cardiologist- Heart Failure & Advanced Echo 
Digital Health - Topol Digital Fellow 2019/2020 
Section editor Cardiology in Focus @heart_bmj